ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,222Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 682

$1.43M Total Retail Price of All Prescriptions

Rank: 45 out of 682

962 Patients Receiving at Least One Drug in Part D
83% Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kentucky
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 962 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 962 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 1,027 898 169 1 3
METOPROLOL TARTRATE 973 866 163 2 11
AMLODIPINE BESYLATE 950 865 133 3 4
OMEPRAZOLE 933 818 162 4 5
SIMVASTATIN 899 809 141 5 6
FUROSEMIDE 858 707 140 6 7
LEVOTHYROXINE SODIUM 713 619 102 7 2
LOVASTATIN 597 555 95 8 75
ATORVASTATIN CALCIUM 530 411 125 9 8
PANTOPRAZOLE SODIUM 502 401 90 10 23
WARFARIN SODIUM 467 446 64 11 15
METFORMIN HCL 435 357 67 12 10
CITALOPRAM HBR 424 352 62 13 20
GABAPENTIN 406 342 68 14 9
CLOPIDOGREL 399 347 62 15 16
ISOSORBIDE MONONITRATE ER 357 338 63 16 40
LOSARTAN POTASSIUM 333 301 52 17 19
METOPROLOL SUCCINATE 314 309* 56 18 17
SERTRALINE HCL 302 235 46 19 25
CARVEDILOL 300 242 55 20 24
ENALAPRIL MALEATE 297 233 36 21 97
HYDROCHLOROTHIAZIDE 289 259 52 22 12
METHYLPREDNISOLONE 273 229 199 23 113
NEXIUM 258 210 48 24 22
NIFEDIPINE ER 257 239 43 25 132
NAMENDA 252 238 24 26 29
DONEPEZIL HCL 250 250 37 27 33
FLUTICASONE PROPIONATE 248 178 113 28 38
ATENOLOL 240 208 37 29 21
MONTELUKAST SODIUM 235 177 41 30 31
ZETIA 233 140 33 31 68
SPIRONOLACTONE 221 160 36 32 65
HYDRALAZINE HCL 217 203 40 33 76
GLIMEPIRIDE 215 197 32 34 44
TAMSULOSIN HCL 211 192 39 35 37
ZOLPIDEM TARTRATE 206 175 43 36 28
RANITIDINE HCL 203 176 48 37 30
ESCITALOPRAM OXALATE 190 148 34 38 46
LEVOFLOXACIN 189 154 145 39 59
CLONIDINE HCL 183 166 29 40 56
BENAZEPRIL HCL 172 130 24 41 94
DIOVAN 172 156 27 41 50
KLOR-CON 10 165 100 18 43 147
MIRTAZAPINE 164 159* 29 44 51
ALLOPURINOL 162 157* 20 45 35
TRAZODONE HCL 161 156* 37 46 41
MELOXICAM 161 156* 44 46 27
POLYETHYLENE GLYCOL 3350 156 133 32 48 48
PRAVASTATIN SODIUM 154 124 30 49 13
LOSARTAN-HYDROCHLOROTHIAZIDE 151 151 22 50 53
POTASSIUM CHLORIDE 148 132 30 51 14
CEFUROXIME 146 118 110 52 156
SYNTHROID 143 128 17 53 52
PAROXETINE HCL 141 125 24 54 58
ABILIFY 137 <11 <11 A 55 140
HYDROCODONE-ACETAMINOPHEN 137 104 53 S3 55 1
ADVAIR DISKUS 134 116 22 57 63
DIGOX 125 120* 21 58 84
PREDNISONE 124 105 84 59 42
QUETIAPINE FUMARATE 124 124 15 A 59 71
FAMOTIDINE* 123 107 25 61 93
PROAIR HFA 122 83 40 62 43
TIZANIDINE HCL 120 95 41 63 78
ALENDRONATE SODIUM 115 102 14 64 49
GLIPIZIDE 114 109* 16 65 61
DILTIAZEM 24HR CD 112 101 21 66 130
LANTUS 112 83 17 66 69
CIPROFLOXACIN HCL 111 92 85 68 67
CRESTOR 110 79 22 69 26
NIASPAN 108 103* 16 70 156
LOVAZA 107 81 14 71 106
TAZTIA XT 106 106 12 10 72 346
JANUVIA 103 92 20 73 54
SPIRIVA 103 80 22 73 57
BUSPIRONE HCL 101 53 21 75 87
VALSARTAN-HYDROCHLOROTHIAZIDE 97 97 16 76 98
RAMIPRIL 95 75 14 77 96
LISINOPRIL-HYDROCHLOROTHIAZIDE 94 79 17 78 39
TRIAMTERENE-HCTZ 93 81 14 79 62
PROPRANOLOL HCL 89 77 13 80 137
CYMBALTA 88 34 21 81 45
AMLODIPINE BESYLATE-BENAZEPRIL 83 <11 <11 82 85
CELEBREX 83 69 16 82 82
INSULIN SYRINGE* 82 54 16 84 131
AZITHROMYCIN 82 71 70 84 55
GLYBURIDE 78 50 15 R 86 104
ALPRAZOLAM 76 71* 27 B 87 18
LORAZEPAM 76 71* 15 B 87 34
FLUOXETINE HCL 75 63 13 89 64
NAPROXEN 73 61 29 90 102
BUPROPION HCL SR 65 50 13 91 200
FENOFIBRATE* 64 59* 11 92 66
MECLIZINE HCL 63 63 22 93 116
NOVOLOG 62 47 14 94 126
DIAZEPAM 61 <11 <11 B 95 47
CLONAZEPAM 60 <11 <11 B 96 36
GEMFIBROZIL 59 40 13 97 128
FINASTERIDE 58 <11 <11 98 114
TRAMADOL HCL 58 53* 27 98 32
DILTIAZEM 24HR ER 58 53* 11 98 129
EVISTA 57 <11 <11 101 121
KLOR-CON M20 57 52* 17 101 74
LEVEMIR 56 32 11 103 155
CYCLOBENZAPRINE HCL 55 <11 <11 R 104 77
NITROGLYCERIN PATCH 53 <11 <11 105 221
LEVEMIR FLEXPEN 53 36 12 105 164
BYSTOLIC 53 <11 <11 105 101
DIVALPROEX SODIUM 53 <11 <11 105 86
THEOPHYLLINE ANHYDROUS 52 <11 <11 109 178
DILTIAZEM ER 52 52 12 109 171
AMITRIPTYLINE HCL 52 47* 12 R 109 60
RISPERIDONE 51 46* 12 A 112 89
ROPINIROLE HCL 50 <11 <11 113 73
ONDANSETRON HCL* 50 30 29 113 165
NASONEX 50 45* 30 113 216
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.